Dr. Debra Curtis, M.D

NPI: 1083729065
Total Payments
$6,181
2024 Payments
$1,129
Companies
40
Transactions
334
Medicare Patients
8,888
Medicare Billing
$658,996

Payment Breakdown by Category

Food & Beverage$6,019 (97.4%)
Education$162.54 (2.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $6,019 331 97.4%
Education $162.54 3 2.6%

Top Paying Companies

Company Total Records Latest Year
Novo Nordisk Inc $1,167 72 $0 (2024)
ABBVIE INC. $935.03 55 $0 (2024)
Lilly USA, LLC $679.35 34 $0 (2024)
Astellas Pharma US Inc $545.03 21 $0 (2024)
Merck Sharp & Dohme LLC $263.78 13 $0 (2024)
Amarin Pharma Inc. $230.94 13 $0 (2022)
Abbott Laboratories $215.48 10 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $194.59 10 $0 (2022)
AstraZeneca Pharmaceuticals LP $187.43 12 $0 (2024)
PFIZER INC. $182.94 11 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,129 57 ABBVIE INC. ($290.24)
2023 $1,319 65 Astellas Pharma US Inc ($367.35)
2022 $1,257 71 ABBVIE INC. ($313.93)
2021 $655.42 42 AbbVie Inc. ($252.61)
2020 $732.17 42 Novo Nordisk Inc ($179.39)
2019 $216.57 13 Novo Nordisk Inc ($38.19)
2018 $211.27 14 PFIZER INC. ($40.27)
2017 $661.60 30 Novo Nordisk Inc ($219.21)

All Payment Transactions

334 individual payment records from CMS Open Payments — Page 1 of 14

Date Company Product Nature Form Amount Type
12/18/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $15.18 General
Category: NEUROSCIENCE
12/10/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $22.66 General
Category: Diabetes
12/06/2024 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $4.54 General
Category: NEUROSCIENCE
11/21/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $17.29 General
Category: Diabetes
11/12/2024 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $34.40 General
Category: Oncology
11/07/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $19.31 General
Category: Inflammation
11/05/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $17.06 General
Category: NEUROSCIENCE
10/30/2024 ABBVIE INC. UBRELVY (Drug), SYNTHROID Food and Beverage In-kind items and services $24.04 General
Category: NEUROSCIENCE
10/30/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $17.70 General
Category: Respiratory
10/22/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $19.60 General
Category: Cardiovascular and Metabolism
10/11/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $19.44 General
Category: Gastroenterology
10/10/2024 Lilly USA, LLC MOUNJARO (Drug), ZEPBOUND Food and Beverage In-kind items and services $18.48 General
Category: Diabetes
10/08/2024 Merck Sharp & Dohme LLC GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 Food and Beverage In-kind items and services $32.18 General
Category: VACCINE
09/26/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $19.13 General
Category: NEUROSCIENCE
09/05/2024 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $23.70 General
Category: Biological
08/27/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $20.60 General
Category: NEUROSCIENCE
08/23/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $2.65 General
Category: NEUROSCIENCE
08/19/2024 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $6.10 General
Category: Biological
08/15/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $11.46 General
Category: NEUROSCIENCE
08/13/2024 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $5.19 General
Category: Biological
08/08/2024 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $20.39 General
Category: NEUROSCIENCE
08/07/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $15.74 General
Category: Diabetes
07/30/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $26.96 General
Category: NEUROSCIENCE
07/25/2024 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $28.00 General
Category: Biological
07/11/2024 Amphastar Pharmaceuticals, Inc. Food and Beverage In-kind items and services $17.74 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 21 2,365 2,978 $551,149 $159,779
2022 25 2,646 3,425 $683,853 $229,432
2021 24 1,750 2,186 $399,116 $132,141
2020 31 2,127 2,877 $449,011 $137,644
Total Patients
8,888
Total Services
11,466
Medicare Billing
$658,996
Procedure Codes
101

All Medicare Procedures & Services

101 procedure records from CMS Medicare Utilization — Page 3 of 5

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 50 57 $21,322 $6,645 31.2%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 43 43 $19,367 $5,498 28.4%
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2021 25 25 $10,516 $4,464 42.5%
90670 Pneumococcal vaccine for injection into muscle Office 2021 18 18 $7,606 $4,322 56.8%
99495 Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge Office 2021 18 19 $7,832 $3,120 39.8%
G0008 Administration of influenza virus vaccine Office 2021 129 130 $9,454 $2,289 24.2%
99490 Chronic care management services, first 20 minutes of clinical staff time per calendar month Office 2021 32 98 $9,053 $2,197 24.3%
G0444 Annual depression screening, 15 minutes Office 2021 106 106 $4,670 $2,152 46.1%
99497 Advance care planning by the physician or other qualified health care professional, first 30 minutes Office 2021 21 21 $4,941 $1,643 33.3%
G0442 Annual alcohol misuse screening, 15 minutes Office 2021 75 75 $2,949 $1,523 51.6%
93000 Routine ekg using at least 12 leads including interpretation and report Office 2021 129 136 $8,797 $1,418 16.1%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 20 20 $6,008 $1,345 22.4%
77080 Bone density measurement of the core or central skeleton (e.g., hips, pelvis, spine) Office 2021 20 20 $2,700 $842.60 31.2%
90756 Vaccine for influenza derived from cell cultures for injection into muscle, quadrivalent, antibiotic free, 0.5ml dosage Office 2021 18 19 $1,249 $520.99 41.7%
G0009 Administration of pneumococcal vaccine Office 2021 29 29 $2,081 $511.29 24.6%
36415 Insertion of needle into vein for collection of blood sample Office 2021 142 168 $1,344 $502.91 37.4%
99439 Chronic care management services, each additional 20 minutes of clinical staff time per calendar month Office 2021 13 14 $1,414 $354.86 25.1%
G0403 Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report Office 2021 27 27 $1,252 $246.05 19.6%
81002 Urinalysis, manual test Office 2021 26 29 $261.00 $100.92 38.7%
96127 Brief emotional or behavioral assessment Office 2021 16 20 $372.00 $56.44 15.2%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2020 229 229 $57,529 $29,063 50.5%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 289 598 $138,437 $21,171 15.3%
99497 Advance care planning by the physician or other qualified health care professional Office 2020 120 143 $24,152 $10,088 41.8%
99490 Chronic care management services at least 20 minutes per calendar month Office 2020 71 291 $26,673 $9,367 35.1%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 177 244 $38,074 $6,518 17.1%

About Dr. Debra Curtis, M.D

Dr. Debra Curtis, M.D is a Internal Medicine healthcare provider based in Catonsville, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083729065.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Debra Curtis, M.D has received a total of $6,181 in payments from pharmaceutical and medical device companies, with $1,129 received in 2024. These payments were reported across 334 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($6,019).

As a Medicare-enrolled provider, Curtis has provided services to 8,888 Medicare beneficiaries, totaling 11,466 services with total Medicare billing of $658,996. Data is available for 4 years (2020–2023), covering 101 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Location Catonsville, MD
  • Active Since 08/20/2006
  • Last Updated 01/22/2018
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1083729065

Products in Payments

  • VRAYLAR (Drug) $438.27
  • Ozempic (Drug) $426.38
  • Rybelsus (Drug) $393.11
  • Veozah (Drug) $375.82
  • JARDIANCE (Drug) $307.62
  • UBRELVY (Drug) $252.17
  • TRULICITY (Drug) $241.73
  • Vascepa (Drug) $230.94
  • MOUNJARO (Drug) $202.14
  • NURTEC ODT (Drug) $200.32
  • QULIPTA (Drug) $186.50
  • Cologuard Collection Kit (Device) $170.93
  • XIFAXAN (Drug) $149.41
  • FARXIGA (Drug) $133.63
  • QUVIVIQ (Drug) $123.74
  • NIOX VERO DEVICE (Device) $110.00
  • Tresiba (Drug) $110.00
  • Victoza (Drug) $106.03
  • EMGALITY (Drug) $101.75
  • ZOSTAVAX (Biological) $88.87

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Catonsville